Not checked for notices yet.
The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.
Andrzej Lange, Emilia Jaskula, Janusz Lange and 5 more
PLoS ONE · 2018
doi:10.1371/journal.pone.0190525
Cited by papers we hold 1
- FLT3 inhibitors in acute myeloid leukemia · 2018No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.